Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Brought to you by:
atrial fibrillation
MedTech
Boston Scientific resumes Farapulse study in first-line afib
Boston Scientific aims to see if Farapulse can deliver results for patients with atrial fibrillation before they take any anti-arrhythmic medications.
Conor Hale
Nov 11, 2024 9:35am
FDA approves J&J’s Varipulse pulsed field ablation system
Nov 7, 2024 3:00pm
Boston Scientific bolsters pulsed field ablation with Cortex buy
Nov 4, 2024 11:00am
FDA approves Medtronic's Affera 2-in-1 afib ablation system
Oct 25, 2024 12:00pm
FDA OKs Boston Scientific’s nav-equipped pulsed field catheter
Oct 21, 2024 10:52am
Abbott advances clinical studies in pulsed field ablation
Oct 11, 2024 2:00pm